Product Program year 2019 Source: CMS Open Payments

ReDS

Device Heart Failure Device.

Open in the dashboard

General payments

$25,447

68 payments

Research payments

$0

0 payments

Through program year 2019, $25,447 in general payments and $0 in research payments were reported against ReDS (Heart Failure Device.).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $25,447 68

Breakdown

Who paid General payments · program year 2019
  1. Medicure Pharma Inc. $25,447 68 payments
Top recipients General payments · program year 2019
  1. William Peacock Emergency Medicine · Houston, TX $6,764 27% · 7 payments
  2. Daniel Bensimhon Advanced Heart Failure and Transplant Cardiology · Greensboro, NC $3,000 12% · 1 payment
  3. Stephen Zouzoulas Advanced Heart Failure and Transplant Cardiology · Concord, NC $1,938 8% · 3 payments
  4. Scott Feitell Advanced Heart Failure and Transplant Cardiology · Rochester, NY $1,500 6% · 1 payment
  5. Sean Pinney Advanced Heart Failure and Transplant Cardiology · New York, NY $1,200 5% · 1 payment

The top 5 of 47 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Advanced Heart Failure and Transplant Cardiology Internal Medicine $10,007 39% · 8 practitioners
  2. Emergency Medicine $9,097 36% · 5 practitioners
  3. Cardiovascular Disease Internal Medicine $4,472 18% · 21 practitioners
  4. Interventional Cardiology Internal Medicine $1,451 6% · 8 practitioners
  5. Internal Medicine $214 <1% · 1 practitioner

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Ohio $6,779 27% · 2 recipients
  2. North Carolina $4,938 19% · 2 recipients
  3. New York $2,700 11% · 2 recipients
  4. Michigan $2,534 10% · 4 recipients
  5. Illinois $2,413 9% · 16 recipients

The top 5 of 14 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

68 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record